By: Raymond Nomizu, Co-Founder and Co-CEO, CRIO
Should sponsors play a role in source documentation? This is a long-running debate in clinical research circles, and it’s one that’s worth revisiting in 2026. Source documents are historically captured by sites using a combination of electronic health records (EHRs), paper worksheets and site-specific eSource systems. Protocols and case report forms (CRFs) are typically designed by sponsors.
However, as trials grow more complex and timelines shorten, the advantages of sponsor-provided source templates, including standardization and reduction of site burden, are causing some sponsors to reconsider previous decisions not to provide source templates.
Why Source Documentation Matters Now
Trials are generating more data than ever before, and sponsors are required to demonstrate robust oversight throughout the data lifecycle. As protocols grow more complex, it increases the work required by sites to translate protocols into source document templates and increases the amount of variability in how different sites are interpreting the data collection requirements.
Variability in source documentation can create reconciliation challenges, increasing query volume and complicating monitoring and inspections.
Downstream systems such as electronic data capture (EDC), central monitoring and analytics are solid investments, but they don’t always address the root causes of data issues that arise at the point of patient interaction. This is where early intervention can play a major role in reducing risk and improving execution.
The Case for Sponsor-Provided Source Templates
Improved alignment with protocol and CRFs
When source templates are designed in concert with protocols and case report forms, they more accurately reflect study requirements. This approach reduces the risk of missing required data elements, inconsistent or incomplete data capture or excessive use of ad hoc free-text entries.
Reduced downstream reconciliation
One way to reduce back-and-forth between sites and monitors -- and ensure cleaner datasets at database lock -- is to implement standardized source layouts. Minimizing discrepancies between source documents and EDC systems is another important benefit. Standardization and EDC harmonization both speed up the monitoring process, leading to faster visit review cycles and fewer backlogs.
Faster site startup and onboarding
Time savings is another crucial, impactful benefit of sponsor-provided templates. When templates are already available, it eliminates the need for sites to create study-specific source documents from scratch. There is also less room for misinterpretation with protocols, which leads to more consistent data capture across sites. Sites using a centrally designed source template have typically seen enrollment timelines that are 30-40 days shorter.
Stronger sponsor oversight
Giving sponsors greater visibility into the data collection process upfront helps limit unforeseen issues down the road during audits or inspections.
When sponsors take a more active role in the development of source document templates, they can realize these and many other benefits to improve trial performance.
The Risks That Sponsors Worry About
Despite these advantages, some sponsors are still skeptical.
Regulatory guardrails
Sponsors want to support better data capture, but they don’t want to encroach on the purview of site investigators. Questions around data ownership, oversight and inspection expectations need to be carefully considered.
Site pushback and adoption risk
Each site has its own unique daily practices, including its own workflow, staffing and technology tools. Adoption of sponsor-provided source is dependent on the alignment of the template with the site’s existing operations. When this mismatch occurs, sites may revert to shadow charts or reject the sponsor-provided templates.
Operational complexity
Implementing source templates across multiple sites requires a clear delineation of roles and consistent communication. Without these elements, templates can add complexity rather than reduce it.
These challenges highlight why the way that templates are introduced is often more important than the templates themselves.
What Experience Shows About Adoption
No two sites are exactly alike, and they know their workflows better than anyone. They are much more receptive to templates when they feel that it will support, rather than replace, their existing processes. Sites want to hear about the tangible ways that source templates will reduce rework and queries. Templates should be developed in close collaboration with sites and never be based solely on CRFs to achieve significant uptake. Moreover, if the centrally designed template can accommodate site-specific configurations, it increases the likelihood of broader site adoption.
Studies that follow these principles are the ones that see improvements with their startup timelines and data consistency.
How CROs can bridge the gap
Contract research organizations (CROs) have a crucial role to play in this process. They manage operational execution, support sites and bridge the divides between sponsors and sites.
CRO involvement is particularly critical as it relates to:
- Translating sponsor expectations into site-friendly workflows.
- Supporting training and onboarding.
- Monitoring adoption and identifying issues early.
- Feeding operational insights back into study design.
CROs who participate early in source design discussions help ensure templates are a net-positive for sites.
Designing Templates That Work In The Real World
Several design principles can improve the likelihood of success.
Design for source first, not EDC first
Data needs to be observed and recorded not only downstream, but at the point of patient interaction. High-quality data prioritizes site usability.
Harmonize early
Study setup is the preferred time to align protocol, source templates and CRFs. When discrepancies between source and CRFs are only addressed after the fact, it adds confusion and creates additional hurdles.
Accept controlled variation
There is no one-size-fits all solution for mapping data elements across systems. Successful programs prioritize flexibility in addition to accurate data capture. Sites are much more likely to adopt templates that can adapt to their local requirements.
Simplify the protocol amendment process
Templates must be updated with each protocol amendment, which means that efficiencies gained through centralized template management are recognized not only during study startup but throughout the execution of the study.
Regulatory Misconceptions
There is a common misconception that when sponsors are involved in the creation of source document templates, it creates regulatory risk.
In fact, when done correctly, sponsor-provided source document templates can reduce regulatory risk and support quality by design (QBD) as introduced by ICH E6 R3. Two keys to making this allowable from a regulatory perspective are:
- This should be optional for investigators as they are ultimately responsible for ensuring that the data collected is appropriate for the study based on the protocol.
- Sites must own the data that is collected regardless of the template or system used to collect the data.
- Sites must be free to capture the data as they observe it, so a template cannot overly constrain freedom to capture (e.g., by adding color commentary) or coerce a certain answer output.
Looking Ahead: What This Means for Sponsors
Sponsor-provided templates provide a compelling opportunity to improve upstream trial execution. However, in today’s world of increasingly complex and data-driven trials, the opportunity comes with important caveats. Thoughtful design, optional adoption and effective communication between CROs and sites will make all the difference for sponsors looking to realize the benefits of these tools.
Conversations should center around how templates can reduce burden, enhance clarity and support sites to improve trial performance.
About The Author
Prior to cofounding CRIO, Raymond Nomizu owned and operated a clinical research site. As Co-CEO, he leads product development, engineering, and corporate strategy. He has over 10 years of management consulting experience including his time with the Boston Consulting Group, and he also founded Bench Core, a real estate data analytics company acquired by RefineRE. Raymond began his career as an attorney and holds J.D. and B.A. degrees from Harvard University.